Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- CheckyesterdayChange DetectedUpdated revision to v3.0.2 and removed the 'Back to Top' link; no substantive content changes detected.SummaryDifference0.4%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.4%
- Check15 days agoChange DetectedThe web page has been updated to include a facility name and location, along with a comprehensive list of study statuses spanning several years. However, several location-related terms have been removed.SummaryDifference97%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has updated its version from v2.16.11 to v2.16.12 and changed the date from 2025-02-10 to 2025-08-11.SummaryDifference1.0%
- Check37 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.